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Abstract 
Background 
Brain derived neurotrophic factor (BDNF) has been implicated in the pathogenesis of 
major depressive disorder (MDD). Existing data on exercise treatment in people with 
MDD are inconsistent concerning the effect of exercise on BDNF pointing either to 
increased or unaltered BDNF concentrations. However, studies in non-depressed 
persons demonstrated a significant effect on resting peripheral BDNF concentrations 
in aerobic training interventions. Given the lack of clarity mentioned above, the 
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current study aimed at examining the effect of adjunctive exercise on serum BDNF 
levels in guideline based treated patients with MDD. 
 
Methods 
42 depressed inpatients were included, and randomized either to a 6 week structured 
and supervised exercise intervention plus treatment as usual (EXERCISE, n=22), or 
to treatment as usual (TAU, n=20). BDNF serum concentrations were assessed 
before and after the intervention in both study groups with established 
immunoassays.   
Results 
Serum BDNF slightly decreased in the TAU group, whilst there was an increase in 
BDNF levels in the exercise group. There was a significant time x group effect 
concerning sBDNF (p=0.030) with repeated ANOVA measures with age and BMI as 
covariates, suggesting an increase in BDNF concentrations in the EXERCISE group 
compared to TAU. 
Limitations 
Though there was no statistic difference in the antidepressant medication between 
EXERCISE and TAU potential interactions between exercise and medication on the 
effects of exercise in BDNF cannot be excluded. Gender was not considered as a 
covariate in ANOVA due to the small number of objects.  
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Conclusions 
Exercise training given as adjunct to standard guideline based treatment appears to 
have additional effects on BDNF serum concentrations in people with MDD. Our 
results add further evidence to the beneficial effects of exercise in the treatment of 
MDD. 
Keywords 
BDNF, aerobic exercise, major depressive disorder, exercise intervention 
Introduction 
Depression is a leading cause of global years lived with disability (Ferrari et al., 2010) 
and is associated with profound economic costs (Chisholm D et al., 2016). People 
with depression are also at increased risk of premature mortality, largely attributed to 
cardiovascular and metabolic disease (Walker et al., 2015) typically engage in low 
levels of physical activity and have low cardiorespiratory fitness levels (Vancampfort 
et al., 2016). However, physical activity interventions can increase cardiorespiratory 
fitness levels in people with depression (Vancampfort et al., 2016) and improve 
symptoms of depression (Schuch FB et al., 2016c). The exact neurobiological 
processes by which exercise improves depressive symptoms in people with major 
depressive disorder have not been clearly elucidated to date (Schuch FB et al., 
2016a).  
One factor that has been implicated in possible accounting for the neurobiological 
response and a target for exercise in people with depression is brain derived 
neurotrophic factor (BDNF). BDNF is a protein which has a significant role in 
neurogenesis, neuroprotection, neuroregeneration and synaptic plasticity (Mattson et 
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al., 2004) and high levels of BDNF mRNA are found in the hippocampus and the 
cerebral cortex (Wetmore et al., 1990).  
Plasma (pBDNF) and serum BDNF (sBDNF) levels have been observed to be 
decreased in people with MDD (Polyakova et al., 2015). Antidepressant drug 
treatment increases sBDNF in depressed patients either in responders or remitters 
(Polyakova et al., 2015).  
Existing data on exercise treatment in people with MDD are inconsistent concerning 
the effect of exercise on BDNF pointing either to increased or unaltered BDNF 
concentrations (Lamego et al., 2015; Salehi et al., 2014; Schuch et al., 2014; Toups 
et al., 2011, Schuch et al., 2016a) However, studies in non-depressed persons 
demonstrated a significant effect on resting peripheral BDNF concentrations in 
aerobic training interventions but not in resistance training (Huang T et al., 2014).  
Given the lack of clarity mentioned above, the current study aimed at examining the 
effect of adjunctive exercise on sBDNF levels in guideline based treated patients with 
MDD. 
 
Methods and Materials 
Participants 
Study participants took part in a randomized pilot trial comparing the effects of 
adjunctive exercise on physiological and psychological parameters in depression 
(Kerling et al., 2015). The study was approved by the local ethics committee; after 
complete description of the study to the subjects, written informed consent was 
obtained. Forty-two inpatients with MDD treated at the Department of Psychiatry, 
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Social Psychiatry and Psychotherapy, Hannover Medical School were included. 
Diagnoses was made according to the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition (DSM-IV) criteria and confirmed with standardized clinical 
interviews (SCID I/II; German version).  
Exercise training was given as adjunct to guideline based treatment as usual (TAU). 
TAU consisted of psychotherapy for each patient, plus antidepressant medication 
according to participated decision making. Patients were randomized either to a 6 
week structured and supervised exercise intervention plus treatment as usual 
(EXERCISE, n=22), or to treatment as usual (TAU, n=20). 
 
None of the patients used ß-blockers or received other cardiologic treatments. Both 
groups did not differ in antidepressant pharmacological treatment (see table 1). 
Medication did not change throughout the intervention.   
Exclusion criteria were body-mass index ≥ 30, age younger than 18 years and over 
60 years, acute or chronic infectious disease, current or lifetime immunological 
disorders, diabetes mellitus type 1 and type 2, current or lifetime cardiovascular 
disorders, pregnancy, schizophrenia, mental retardation, bipolar disorder, and current 
substance abuse or dependency. 
Blood sampling 
Fasting serum samples of sBDNF were collected between 0700 h and 0800 h after 
overnight fasting and stored at -80°C until analysis. Coffee and alcohol were not 
allowed for 12h, and morning medication was given after blood sampling. Analysis 
was performed in duplicate established immunoassays according to the 
manufacturer´s instruction (Quantikine HS® R&D Systems, Inc.; Minneapolis; MN; 
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USA). The immunoassay measures total sBDNF, i.e. free BDNF, trk-bound BDNF, 
pro- and mature BDNF, and is calibrated against a highly purified Sf21-expressed 
recombinant human BDNF produced by the manufacturer. The detection range is 
between 15.6 – 1.000 pg/ml. The intra assay coefficient of variation is 2.4-3.2%, the 
inter-assay coefficient of variation is 4.3-7.2% according to the manufacturer. All 
samples were stored no longer than 6 months. 
Spiroergometry/EXERCISE intervention 
The physician supervised training program was performed during hospitalization at 
the MHH Institute of Sports Medicine and consisted of three trainings sessions per 
week for each 45 minutes at moderate intensity. To achieve moderate intensity, 
participants performed a constant load test at 50% of the maximum workload 
achieved during the initial incremental exercise test. At this intensity, all patients 
trained in the aerobic-anaerobic transition zone (above the VAT and below the 
anaerobic lactate threshold). 
The exercise training started with a 25 minute workout phase on a bicycle ergometer 
and training was continued at personal preference on a second endurance machine 
(e.g. treadmill, crosstrainer, rowing). The intervention lasted 6 weeks and all of the 22 
EXERCISE patients completed the study. The patients participated in over 90% of 
the possible training units. Patients in the TAU group were allowed to take part in the 
daily activity program (walking, ball games and stretching exercises for 20 minutes). 
Behavioral assessment, implementation of the spiroergometry and the exact 
performance of the exercise program are described under Kerling et al. (2015). 
 
Statistical Analysis 
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The statistical analysis was performed using SPSS version 22.0 (IBM Corp., Armonk, 
NY, USA) and GraphPad Prism 6 (GraphPad Software Inc., La Jolla, CA, USA). Data 
were tested for a normal distribution using the Kolmogorov–Smirnov test. Group 
effects (Exercise versus TAU) were assessed using two-tailed T-test. The chi-
squared test was used to compare the rates of females and to compare 
antidepressant treatment strategies between remitters and non-remitters. Pearson’s 
product-moment correlation coefficient was used to analyze correlations. Repeated 
measures ANOVA with age and BMI as covariates were used to compare BDNF 
concentrations before and after the intervention in both groups. 
Values are presented as mean  SD. All P values <0.05 were considered to be 
significant.  
 
Results 
For anthropometric and clinical data see table 1. The effects on cardiorespiratory 
fitness, psychological outcome, factors of the metabolic syndrome and on the amount 
of epicardial and subcutaneous adipose tissue were described under Kerling et al. 
(2015) and Kahl KG et al. (2016). 
Comparison of BDNF serum concentrations  
After testing for normal distribution, a repeated ANOVA with age and BMI as 
covariates revealed a significant effect time x group effect concerning sBDNF 
(F=5.05; df=1; p=0.03) (Figure 1, Table 2). Overall, sBDNF slightly decreased in the 
TAU group, and increased in the EXERCISE group (s. Figure 1). However, sBDNF 
alterations over time reached no statistical significance in both groups (sBDNF 
EXERCISE: T=1.52; df=21; p=0.08 versus sBDNF TAU: T=0.81; df=19; 0.42).  
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A correlation analysis with Δ MADRS (relative change in MADRS sum score between 
t0 to t1) and Δ sBDNF (relative change in sBDNF levels between t0 and t1) revealed 
no significant association either for the EXERCISE group, nor for the TAU group 
(data not shown).  
 
 
Discussion 
 The results of this randomized controlled study add evidence to the beneficial effects 
of exercise in the treatment of MDD and suggest that increasing BDNF may be 
associated with the neurobiological mechanisms of exercise in MDD.  
Szuhany et al. (2014) in a review found a moderate effect for increasing BDNF levels 
after single exercise units. Regular exercise improves this effect, and regular 
exercise units increase resting BDNF levels. 
BDNF changes in exercising women were lower (Szuhany et al., 2014). Previous 
literature has demonstrated that exercise training enhances BDNF release from the 
human brain (Seifert et al., 2010) and increases concentrations of serum, plasma and 
platelet BDNF directly after maximum performance (Cho et al., 2012) in healthy 
persons. Even exercise of at least 30 minutes duration induce a temporary increase 
of peripheral BDNF concentrations in healthy persons as well as in patients with 
MDD (Ferris et al., 2007; Gustafsson et al., 2009) wherein the increase in patients 
with MDD is less pronounced. Physiologically sixty minutes after endurance exercise 
increased BDNF levels fall to baseline and even below this (Knaepen et al., 2010). 
Strength training in the majority of studies has no effect on peripheral BDNF levels 
(Huang T et al., 2014). 
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There is a relative paucity of studies and in particular RCTs which have considered 
the relationship between regular aerobic exercise and BDNF in patients with 
depression. Toups et al. found no differences in serum and plasma BDNF before and 
after a 12 week lasting exercise intervention for two groups divided into a low caloric 
and a high caloric expenditure group (Toups et al., 2011). An exact exercise protocol 
with mode or duration of the training sessions was not described. Schuch et al. 
(2014) found no difference in plasma BDNF levels after combined treatment with 
aerobic exercise in depressed patients after 3 weeks but all patients additionally 
received other therapies like electroconvulsive therapy (ECT). A potential factor that 
may have accounted for the lack of effect in this study could be due to the short study 
duration. Salehi et al. (2014) found increasing BDNF levels under aerobic exercise 
training, electroconvulsive therapy and under a combination of both in patients 
suffering from treatment resistant major depressive disorder. Aerobic exercise 
consisted of training on a treadmill three times a week (between 60 and 75% of 
VO2max) for 30 minutes for four weeks. The highest increase of sBDNF was under 
electroconvulsive therapy but the highest decrease of depressive symptoms was 
under combination therapy. BDNF levels in this study were not associated with 
symptoms of depression (Salehi et al., 2014). Lamego et al. (2015) examining the 
effects of aerobic exercise on BDNF and cortisol alterations in depressed patients in 
a review could not establish an interaction between these two biomarkers and 
aerobic exercise. This was due to differences in the types of exercise, duration of the 
sessions, intensity and frequency of weekly sessions and duration of the exercise 
intervention (Lamego et al., 2015). Thus, our randomised study without the use of 
ECT sheds novel light on the potential unique influence of exercise on BDNF levels in 
people with MDD. 
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Some clinical, psychological, social and biological features such as family history of 
mental illness, gender and the interaction between body mass index (BMI) and BDNF 
may be moderators or predictors for an antidepressant effect of exercise in MDD 
(Schuch et al., 2016b). In patients with mild to moderate depression aerobic exercise 
leads to a higher decrease of depressive symptoms in participants presenting higher 
values of BDNF and BMI (Toups et al., 2011).  
Several hypotheses have been built how exercise may influence BDNF levels. In 
animal models BDNF mRNA expression is induced by exercise in several brain 
regions mainly in the hippocampus (Cotmann et al., 2007). One hypothesis is that 
exercise initiates the induction of the expression of a myokine (Fndc5) which induces 
BDNF expression (Wrann et al., 2013). Another mechanism describes that exercise 
may support BDNF promotors (Koppel and Timmusk, 2013) via an endogenous 
molecule which is useful as a metabolite (as an energy source) as well as a regulator 
of BDNF transcription. This way was demonstrated for D-b-hydroxybutyrat (Sleiman 
et al., 2016). 
Heijnen et al. (2016) conclude that aerobic exercise modulates hormone, 
neurotrophin and neurotransmitter levels depending on factors such as genes, age 
and hormonal status and hypothesize that the effect of aerobic exercise depends on 
the initial performance level.  
The finding of decreased BDNF levels in the TAU group deserves further 
interpretation, since most studies found higher sBDNF levels after antidepressant 
treatment (Polyakova et al., 2015). However, in the study by Piccinni et al. lower 
sBDNF level was found after 1 year of treatment (Piccini et al., 2008).The authors 
argue, that lower sBDNF after antidepressant treatment might represent a trait of 
some depressed patients.  
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Limitations 
Though there was no statistic difference in the antidepressant medication between 
EXERCISE and TAU potential interactions between exercise and medication on the 
effects of exercise in BDNF cannot be excluded. Gender was not considered as a 
covariate in ANOVA due to the small number of objects. We decided to use repeated 
measures ANOVA for analysis, however, general estimated equations (GEE) may 
also be useful. 
 
Conclusions 
Exercise training given as adjunct to standard guideline based treatment appears to 
have additional effects on BDNF serum concentrations in people with MDD. Our 
results add further evidence to the beneficial effects of exercise in the treatment of 
MDD. 
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Fig. 1: Exercise increases BDNF concentrations in patients with depression 
 
 
 
Table 1 Anthropometric data, antidepressant medication and depression scores 
Measure 
EXERCISE 
(N=22) 
TAU 
(N=20) 
 
 N % N % P 
Female 10 45 6 30 n.s. 
 Mean SD Mean SD P 
Age 44.2 8.5 40.9 11.9 n.s. 
Height (m) 1.73 0.08 1.75 0.09 n.s. 
Weight (kg) 81.2 20.8 82.1 14.9 n.s. 
BMI 26.8 5.1 26.8 4.8 n.s. 
 N % N % P 
Antidepressants 17 77 15 75 n.s. 
17 
 
 SSRI 5 23 5 25 n.s. 
 SSNRI 5 23 5 25 n.s. 
 NDRI 5 23 4 20 n.s. 
 Agomelatine 6 27 4 20 n.s. 
 Mean SD Mean SD P 
Smoking (pack-years) 5.5 7.2 5.0 8.5 n.s. 
Physical activity before 3.0 1.8 2.6 1.8 n.s. 
Alcoholic Drinks 4.1 6.5 0.8 1.6 0.034 
BDI-2 sum score     n.s. 
 t0 29.4 10.9 28.3 11.2 n.s. 
 t1 13.4* 13.2 15.9* 12.5 n.s. 
 Mean SD Mean SD P 
MADRS sum score     n.s. 
 t0 23.5 8.7 24.5 10.3 n.s. 
 t1 11.8* 10.4 16.4* 9.4 n.s. 
      
    
      
      
 
Legend: Anthropometric and clinical data. Depression scores significantly decreased 
in both intervention groups (marked with an asterisk).  
* means a P-value < 0.05 concerning within group effects after 6 weeks treatment. 
 
 
 
Table 2: BDNF scores 
Measure 
EXERCISE 
(N=22) 
TAU 
(N=20) 
 
 
 Mean SD Mean SD T P 
BDNF score (pg/mL)       
t0 415.2 362.8 454.8 354.3 0.36 n.s. 
t1 472.5 526.1 432.9 335.7 -0.29 0.03 
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